(265 days)
Not Found
No
The summary describes a standard dental x-ray imaging system using computed reconstruction, with no mention of AI or ML in the device description, intended use, or performance studies.
No
The device is described as a diagnostic x-ray imaging system used for detection, examination, and diagnosis of dental abnormalities and diseases, not for therapeutic intervention.
Yes
The "Intended Use / Indications for Use" states that the device is used for the "examination and diagnosis of diseases of the teeth, jaw, and oral structures." Additionally, the "Device Description" explicitly calls NAOMI-CT a "diagnostic x-ray imaging system."
No
The device description explicitly states it is a "diagnostic x-ray imaging system, which consists of computed tomography x-ray system and panoramic x ray system" and utilizes "CMOS and CCD sensors equipped in the system," indicating it includes significant hardware components beyond just software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- NAOMI-CT Function: The NAOMI-CT is an imaging system that uses X-rays to create images of the teeth, jaw, and oral structures within the patient's body. It does not analyze samples taken from the body.
The description clearly states it's a "diagnostic x-ray imaging system" that captures images of the "oral and maxillofacial anatomy on a real time basis." This is the core function of an in vivo (within the living body) diagnostic imaging device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The NAOMI-CT is used to take three- and two-dimensional x-ray images for the detection of dental abnormalities for a purpose of examination and diagnosis of diseases of the teeth, jaw, and oral structures.
Product codes
OAS
Device Description
NAOMI-CT is a diagnostic x-ray imaging system, which consists of computed tomography x-ray system and panoramic x ray system. It is used for detecting oral and maxillofacial abnormalities and diseases of patients of all ages and gender.
NAOMI-CT achieves above by utilizing CMOS and CCD sensors equipped in the system, and captures 3D computed tomography scanned image and 2D Panoramic X ray image of the oral and maxillofacial anatomy on a real time basis by computed reconstruction of x-ray image data from the same axial plane taken at different angles.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-ray
Anatomical Site
oral and maxillofacial anatomy
Indicated Patient Age Range
all ages
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Electrical, mechanical, environmental safety and performance testing according to standard IEC 60601-1, IEC 60601-1-3, IEC 60601-2-7, IEC 60601-2-28, IEC 60601-2-32, and IEC 60601-2-44 was performed, and EMC testing was conducted in accordance with standard IEC 60601-1-2. For clinical and non-clinical considerations, the testing was conducted in accordance with FDA's Guidance for the submission of 510(k)'s for Solid State Xray Imaging Devices. Additionally, High Contrast Resolution, Low Contrast Resolution, Artifact and Dosimetry Evaluation were also performed. All test results were satisfactory.
Non-clinical & Clinical considerations in this submission prove that NAOMI-CT and predicate devices share the same qualities and characteristics. All the results were satisfactory to indicate the equivalence of NAOMI-CT to the predicates.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1750 Computed tomography x-ray system.
(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
510K Summary
07.17.2013 Summary Prepared on . •
JUL 1 8 2013
1. General Information of Submitter and Correspondent
| Applicant | RF Co. Ltd
3 Nakagosho, Nagano, Nagano, 380-0935, JAPAN |
|----------------|------------------------------------------------------------|
| Contact Person | Daisuke Tanaka |
| Telephone | 81-26-225-7744 |
| Fax | 81-26-225-7747 |
| Email | dt.os@rfsys.biz |
- Trade/Proprietary Name:
NAOMI-CT
4. Common Name
Dental Computed Tomography X-ray System
5. Classification Name
Dental Computed Tomography X-ray System (21 CFR 892.1750, Product Code OAS, Class 2)
6. Device Description
NAOMI-CT is a diagnostic x-ray imaging system, which consists of computed tomography x-ray system and panoramic x ray system. It is used for detecting oral and maxillofacial abnormalities and diseases of patients of all ages and gender.
NAOMI-CT achieves above by utilizing CMOS and CCD sensors equipped in the system, and captures 3D computed tomography scanned image and 2D Panoramic X ray image of the oral and maxillofacial anatomy on a real time basis by computed reconstruction of x-ray image data from the same axial plane taken at different angles.
7. Indications for Use
The NAOMI-CT is used to take three- and two-dimensional x-ray images for the detection of dental abnormalities for a purpose of examination and diagnosis of diseases of the teeth, jaw, and oral structures.
8. Predicate Device
TAKARA BELMONT CORP. : BEL-CAT Dental Cone Beam CT (K101181)
1
9. Substantial Equivalence
RF Co. Ltd perceives that NAOMI-CT is substantially equivalent to BEL-CAT Dental Cone Beam CT of Takara Belmont Corp. and E-Woo Dental Imaging System Model EPX-Impla of E-Woo Technology.
The indications for use, performance, safety characteristics and energy source are same for NAOMI-CT and the predicate devices. The primary difference is the cosmetic, structure and component used only.
10. Safety, EMC and Performance Data
Electrical, mechanical, environmental safety and performance testing according to standard IEC 60601-1, IEC 60601-1-3, IEC 60601-2-7, IEC 60601-2-28, IEC 60601-2-32, and IEC 60601-2-44 was performed, and EMC testing was conducted in accordance with standard IEC 60601-1-2. For clinical and non-clinical considerations, the testing was conducted in accordance with FDA's Guidance for the submission of 510(k)'s for Solid State Xray Imaging Devices. Additionally, High Contrast Resolution, Low Contrast Resolution, Artifact and Dosimetry Evaluation were also performed. All test results were satisfactory.
Non-clinical & Clinical considerations in this submission prove that NAOMI-CT and predicate devices share the same qualities and characteristics. All the results were satisfactory to indicate the equivalence of NAOMI-CT to the predicates. .
11. Statement of Compliance with Federal X ray Performance Standards
NAOMI-CT is in compliance with the necessary Federal X ray performance standards.
12. Conclusion
In accordance with the Federal Food, Drug and Cosmetic Act, 21 CFR 807 and based on the information provided in this premarket notification. RF Co. Ltd assures that NAOMI-CT is as safe and effective as the predicate devices as described in this submission, and concludes that NAOMI-CT is substantially equivalent to the already marketed devices.
2
Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three stripes forming its wing and body. The eagle is positioned to the right of a circular text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES · USA".
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drag Administration 10903 New Hampshire Avenue Document Control Center - WO06-G609 Silver Spring, MD 20093-00002
July 18, 2013
RF Co. Ltd. % Ms. Priscilla Chung Regulatory Affairs Consultant I.K Consulting Group USA, Inc. 951 Starbuck Streeet, Unit J FULLERTON CA 92833
Re: K123332
Trade/Device Name: NAOMI-CT Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: Class II Product Code: OAS Dated: June 13, 2013 Received: June 17, 2013
Dear Ms. Chung:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices. good nanufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into cither class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA`s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801): medical device reporting of medical
3
Page 2 - Ms. Chung
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fdagov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
for
Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known): K123332
Device Name: NAOMI-CT
Indications for Use:
The NAOMI-CT is used to take three- and two-dimensional x- ray images for the detection of dental abnormalities for a purpose of examination and diagnosis of diseases of the teeth, jaw, and oral structures..
Prescription Use V (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Smh.7)
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health
K123332 510(k)
Page 1 of _ 1